Stockreport

Spruce: BTD For TA-ERT For MPS IIIB Could Ignite BLA Submission With Added Bonuses (Rating Upgrade) [Seeking Alpha]

Spruce Biosciences, Inc.  (SPRB) 
PDF BTD enables potential rolling BLA submission, Priority Review, and Accelerated Approval pathway, supported by strong 5-year biomarker and clinical data for TA-ERT. Co [Read more]